Company intelligence / Profile preview

BioConsortia

Davis, California, United Statesbioconsortia.com ↗

Ownership: Private
Development stage: Commercial

Overview

BioConsortia has successfully completed field trials demonstrating high efficacy of its microbial fungicides, nematicides, and biostimulants. Products are reported to outperform current biologicals on the market with higher consistency. Several products are advancing through regulatory registration.

Therapeutic areas: Other
Modalities: Microbial therapyLive biotherapeutic product therapyBiostimulantBiopesticide
Industry: Agriculture & AgTech

Drug pipeline

2 assets

Amara

Commercial

Indications: Agricultural fungicide

1 more asset in the full pipeline.

Request access →

Partnerships

Mosaic Company – partnership for commercialization/funding of certain technologies/products within the Americas

Beyond the preview

Go deeper on BioConsortia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioConsortia.

Explore the full profile